Nanning, China, 10–13 September 2021 – MGI showcased a series of innovative platforms at the 18th China-ASEAN Expo, which opened on 10 September in Nanning, China.
At the event, MGI presented multiple platforms, including:
MGISP-960 High-throughput Automated Sample Preparation System, an efficient and widely used automated sample preparation system.
MGISTP-7000 High-throughput Automated Sample Transfer Processing System, designed to significantly improve nucleic acid testing capability.
MGISP-NE384 High-throughput Automated Nucleic Acid Extractor.
DNBSEQ-G50, a compact and flexible benchtop genetic sequencer.
Automation platforms attracting global attention
MGI’s proprietary platforms and technologies made a strong appearance at the 18th China-ASEAN Expo and attracted significant attention from major Chinese media outlets, including China National Radio (CNR) and China News Service.
“We are committed to upgrading our innovative platforms to standardise diagnostic testing laboratories with higher data capacity and greater automation for large-scale nucleic acid detection,” said Lin Siyuan, Director of Mobile Lab at MGI. “MGI’s automation systems have supported more than 50 countries to date, contributing to safeguarding the global community.”
Improving efficiency in nucleic acid testing
MGI’s automation systems can automatically complete barcode identification, tube decapping, liquid transfer and tube recapping, simplifying some of the most labour-intensive and time-consuming procedures in testing laboratories.
The MGISTP-7000 high-throughput automated sample transfer processing system can process up to 6,000 samples per day. The MGISP-NE384 high-throughput automated nucleic acid extractor uses magnetic rod technology and can process up to 10,000 samples per day with a single unit.
The MGISP-960 high-throughput automated sample preparation system is a flexible, fully automated workstation equipped with a 96-channel pipette head. It can process 192 samples in 80 minutes and can be configured to meet the different testing needs of healthcare authorities.
In addition, one laboratory technician can operate up to three instruments simultaneously within a safe working environment.
Supporting global pandemic response
Founded in 2016, MGI now operates in more than 70 countries and regions. The company has established scientific research and production bases, as well as a global training and service network around the world.
MGI has also played an integral role in the global response to COVID-19 by improving the efficiency of large-scale testing while helping ensure safer working environments for laboratory personnel.
